Cabozantinib plus atezolizumab for non-clear cell kidney cancer
In this video interview, Dr Monty Pal from the City [...]
Cabozantinib plus atezolizumab combination for advanced kidney cancer
In this study, two doses of cabozantinib were tested in [...]
Immune-related adverse events from cabozantinib plus atezolizumab as first-line treatment for advanced kidney cancer
The COSMIC-021 clinical trial investigated a combination of cabozantinib and [...]
Cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
In this video interview with Dr Monty Pal from the [...]
Atexolizumab plus bevacizumab for sarcomatoid kidney cancer
A study published in European Urology in July looks at [...]
Patient-reported outcomes with atezolizumab plus bevacizumab in metastatic kidney cancer
This study describes patient-reported outcomes from the phase 3 IMmotion151 [...]
Cabozantinib in combination with immunotherapy for advanced kidney cancer
In this video interview, Dr Monty Pal from the City [...]
Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma
In this video interview from Practice Update, Dr Brad McGregor [...]
Atezolizumab and bevacizumab in patients with advanced non-clear cell renal cell carcinoma
Dr Rana McKay from University of California in San Diego, [...]
Phase Ib cabozantinib plus atezolizumab combination study now open to kidney cancer patients in the UK
Based on promising efficacy findings, the COSMIC-021 clinical trial has [...]
